EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Challenges of assessing the cost effectiveness of AMR campaigns: Considerations for policy makers

Mary Jordan, Abimbola Ayorinde, Iman Ghosh, Junaid Shaikh, Victoria Adetunji, Anna Brown, Ellie Gilham, Daniel Todkill, Diane Ashiru-Oredope

Public Health · 2025

DOI: 10.1016/j.puhe.2025.105877 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Public Health, 2025. Verfasst von Mary Jordan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Warwick Medical School, University of Warwick, Coventry, UK. Electronic address: Mary.jordan@warwick.ac.uk. Hauptthemen laut MEDLINE: Health Policy, Policy Making, Health Promotion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Health Security Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To provide overview and understanding of the current challenges in assessing the cost-effectiveness of antimicrobial resistance (AMR) campaigns and highlight the main considerations for policy makers when evaluating existing and future evidence to inform decision making. STUDY DESIGN: Policy commentary. METHODS: A rapid review of cost-effectiveness analyses evaluating public AMR campaigns highlighted significant challenges with existing methodologies which were reviewed extensively in further literature searches to inform overview and commentary. RESULTS: Longstanding challenges in measuring clinical outcomes for use in economic evaluations and the methodologies available to health economists to evaluate public health campaigns were identified: Identifying and measuring appropriate outcomes, including broader societal impacts, capturing relevant outcomes which result over longer timescales, and accounting for the costs of AMR. These remain significant obstacles in assessing the true cost-effectiveness of interventions. CONCLUSIONS: Little methodological progress has been made in this area over the past 20 years, leaving policy makers in a difficult conundrum when justifying future investment in public campaigns to combat AMR. Evidence of high societal value placed on such interventions suggests future work to establish the cost-effectiveness of public AMR campaigns and support policy making are essential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Health PolicyPolicy MakingHealth PromotionCost-Benefit AnalysisHumansPublic HealthCost-Effectiveness Analysis

Autor:innen und Institutionen

  • Warwick Medical School, University of Warwick, Coventry, UK. Electronic address: Mary.jordan@warwick.ac.uk.
  • Warwick Medical School, University of Warwick, Coventry, UK.
  • UK Health Security Agency, London, UK.
  • UK Health Security Agency, London, UK; School of Pharmacy, University of Nottingham, Nottingham, UK.

Förderung

  • UK Health Security Agency

Zitieren

APA

Jordan, M., Ayorinde, A., Ghosh, I., Shaikh, J., Adetunji, V., Brown, A., Gilham, E., Todkill, D., & Ashiru-Oredope, D. (2025). Challenges of assessing the cost effectiveness of AMR campaigns: Considerations for policy makers. Public Health. https://doi.org/10.1016/j.puhe.2025.105877

Vancouver

Jordan M, Ayorinde A, Ghosh I, Shaikh J, Adetunji V, Brown A, et al. Challenges of assessing the cost effectiveness of AMR campaigns: Considerations for policy makers. Public Health. 2025. doi:10.1016/j.puhe.2025.105877

BibTeX
@article{Jordan2025,
  author = {Jordan, Mary and Ayorinde, Abimbola and Ghosh, Iman and Shaikh, Junaid and Adetunji, Victoria and Brown, Anna and Gilham, Ellie and Todkill, Daniel and Ashiru-Oredope, Diane},
  title = {Challenges of assessing the cost effectiveness of AMR campaigns: Considerations for policy makers},
  journal = {Public Health},
  year = {2025},
  doi = {10.1016/j.puhe.2025.105877}
}
Kostenlos starten →